|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.804
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.514
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.427
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.394
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.323
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.321
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.320
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.310
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.283
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.280
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.276
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.270
|
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
65 |
0.262
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.258
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.248
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.244
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.226
|
|
|
|
positive regulation of cytokine biosynthetic process
|
GO:0042108 |
40 |
0.215
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.212
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.209
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.200
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.196
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.192
|
|
|
|
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002822 |
87 |
0.191
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.190
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.188
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.187
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.184
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.184
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.179
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.178
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.177
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.174
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.172
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.167
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.164
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.164
|
|
|
|
regulation of lymphocyte mediated immunity
|
GO:0002706 |
84 |
0.162
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.161
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.160
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.159
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.155
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.153
|
|
|
|
granulocyte chemotaxis
|
GO:0071621 |
39 |
0.153
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.150
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.150
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.148
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.148
|
|
|
|
release of sequestered calcium ion into cytosol
|
GO:0051209 |
42 |
0.147
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.143
|
|
|
|
myeloid leukocyte migration
|
GO:0097529 |
57 |
0.142
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.140
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.140
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.140
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.137
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.137
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.135
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.133
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.133
|
|
|
|
immunoglobulin mediated immune response
|
GO:0016064 |
69 |
0.133
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.127
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.127
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.126
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.125
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.124
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.124
|
|
|
|
positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002824 |
61 |
0.120
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.120
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.119
|
|
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.117
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.113
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.112
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.111
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.111
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.110
|
|
|
|
sensory perception of pain
|
GO:0019233 |
47 |
0.110
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.110
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.109
|
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.108
|
|
|
|
regulation of hormone secretion
|
GO:0046883 |
88 |
0.108
|
|
|
|
regulation of immunological synapse formation
|
GO:2000520 |
2 |
0.108
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
70 |
0.108
|
|
|
|
leukocyte chemotaxis
|
GO:0030595 |
69 |
0.108
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.105
|
|
|
|
regulation of cytokine biosynthetic process
|
GO:0042035 |
59 |
0.105
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.104
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.104
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.102
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.102
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.101
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.100
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.099
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.099
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.099
|
|
|
|
regulation of peptide hormone secretion
|
GO:0090276 |
75 |
0.096
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.095
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.095
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.094
|
|
|
|
granulocyte migration
|
GO:0097530 |
43 |
0.094
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.093
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.092
|
|
|
|
positive regulation of lymphocyte mediated immunity
|
GO:0002708 |
62 |
0.091
|
|
|
|
negative regulation of homeostatic process
|
GO:0032845 |
71 |
0.091
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.091
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.090
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.089
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.089
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.089
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.089
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.089
|
|
|
|
adenylate cyclase modulating g protein coupled receptor signaling pathway
|
GO:0007188 |
54 |
0.089
|
|
|
|
b cell proliferation
|
GO:0042100 |
53 |
0.088
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.087
|
|
|
|
immunoglobulin production
|
GO:0002377 |
73 |
0.087
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.086
|
|
|
|
regulation of t cell proliferation
|
GO:0042129 |
92 |
0.086
|
|
|
|
positive regulation of chemotaxis
|
GO:0050921 |
38 |
0.086
|
|
|
|
positive regulation of monocyte extravasation
|
GO:2000439 |
1 |
0.086
|
|
|
|
cellular modified amino acid metabolic process
|
GO:0006575 |
63 |
0.085
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.085
|
|
|
|
alpha beta t cell differentiation
|
GO:0046632 |
69 |
0.085
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.084
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.084
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.084
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.083
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.082
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.082
|
|
|
|
regulation of chemotaxis
|
GO:0050920 |
53 |
0.081
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.081
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.080
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.080
|
|
|
|
b cell mediated immunity
|
GO:0019724 |
71 |
0.080
|
|
|
|
insulin secretion
|
GO:0030073 |
89 |
0.080
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.080
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.080
|
|
|
|
formation of primary germ layer
|
GO:0001704 |
77 |
0.080
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.079
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
64 |
0.078
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.078
|
|
|
|
somatotropin secreting cell differentiation
|
GO:0060126 |
4 |
0.077
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.076
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.076
|
|
|
|
protein kinase c activating g protein coupled receptor signaling pathway
|
GO:0007205 |
4 |
0.075
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.075
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.075
|
|
|
|
signal transduction in absence of ligand
|
GO:0038034 |
55 |
0.075
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.075
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.075
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.074
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.074
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.073
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.073
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.073
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.073
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.072
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.072
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.072
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.072
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.072
|
|
|
|
regulation of calcium ion transport
|
GO:0051924 |
69 |
0.072
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.071
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.071
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.071
|
|
|
|
g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger
|
GO:0007187 |
55 |
0.070
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.070
|
|
|
|
telencephalon cell migration
|
GO:0022029 |
55 |
0.069
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.067
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.067
|
|
|
|
cytokine biosynthetic process
|
GO:0042089 |
68 |
0.066
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.065
|
|
|
|
cytosolic calcium ion transport
|
GO:0060401 |
48 |
0.065
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.065
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.065
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.065
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.064
|
|
|
|
monocyte extravasation
|
GO:0035696 |
2 |
0.063
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.063
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.062
|
|
|
|
eosinophil activation
|
GO:0043307 |
1 |
0.062
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.061
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.061
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.061
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.061
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.061
|
|
|
|
cytokine metabolic process
|
GO:0042107 |
71 |
0.061
|
|
|
|
leukocyte homeostasis
|
GO:0001776 |
79 |
0.061
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.061
|
|
|
|
forebrain cell migration
|
GO:0021885 |
58 |
0.060
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.060
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.059
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.059
|
|
|
|
positive regulation of behavior
|
GO:0048520 |
40 |
0.059
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.059
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.058
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.058
|
|
|
|
positive regulation of monocyte chemotaxis
|
GO:0090026 |
2 |
0.058
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.058
|
|
|
|
positive regulation of t cell costimulation
|
GO:2000525 |
2 |
0.058
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.058
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.057
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.057
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.057
|
|
|
|
mature dendritic cell differentiation
|
GO:0097029 |
3 |
0.056
|
|
|
|
regulation of peptide transport
|
GO:0090087 |
91 |
0.056
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.056
|
|
|
|
regulation of interleukin 1 production
|
GO:0032652 |
26 |
0.056
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.056
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.055
|
|
|
|
positive regulation of response to wounding
|
GO:1903036 |
66 |
0.055
|
|
|
|
phospholipase c activating g protein coupled receptor signaling pathway
|
GO:0007200 |
26 |
0.054
|
|
|
|
regulation of t cell costimulation
|
GO:2000523 |
2 |
0.054
|
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.053
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.053
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.053
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.053
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.053
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.053
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.052
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.052
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.052
|
|
|
|
regulation of b cell proliferation
|
GO:0030888 |
39 |
0.052
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.051
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.051
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.050
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.050
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.050
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.050
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.049
|
|
|
|
antigen processing and presentation
|
GO:0019882 |
47 |
0.049
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.049
|
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.049
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.049
|
|
|
|
regulation of cardiac muscle tissue development
|
GO:0055024 |
31 |
0.049
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.048
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.048
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.048
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.048
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.048
|
|
|
|
positive regulation of t cell receptor signaling pathway
|
GO:0050862 |
4 |
0.047
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.047
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.047
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.047
|
|
|
|
positive regulation of adaptive immune response
|
GO:0002821 |
61 |
0.047
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.047
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.047
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.047
|
|
|
|
positive regulation of inflammatory response
|
GO:0050729 |
47 |
0.046
|
|
|
|
regulation of peptide secretion
|
GO:0002791 |
77 |
0.046
|
|
|
|
feeding behavior
|
GO:0007631 |
62 |
0.046
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.046
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.046
|
|
|
|
phenol containing compound metabolic process
|
GO:0018958 |
60 |
0.046
|
|
|
|
lung morphogenesis
|
GO:0060425 |
50 |
0.046
|
|
|
|
striated muscle adaptation
|
GO:0014888 |
26 |
0.046
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.046
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.046
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.046
|
|
|
|
regulation of monocyte chemotaxis
|
GO:0090025 |
3 |
0.046
|
|
|
|
positive regulation of cell division
|
GO:0051781 |
31 |
0.045
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.045
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.045
|
|
|
|
neutrophil migration
|
GO:1990266 |
37 |
0.045
|
|
|
|
acute inflammatory response
|
GO:0002526 |
41 |
0.045
|
|
|
|
positive regulation of nucleotide biosynthetic process
|
GO:0030810 |
26 |
0.045
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.045
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.044
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.044
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.044
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.044
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.044
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.044
|
|
|
|
regulation of immunoglobulin mediated immune response
|
GO:0002889 |
37 |
0.044
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.044
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.044
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.044
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.044
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.044
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.043
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.043
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.043
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.043
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.043
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.043
|
|
|
|
negative regulation of phagocytosis
|
GO:0050765 |
4 |
0.043
|
|
|
|
positive regulation of t cell extravasation
|
GO:2000409 |
2 |
0.042
|
|
|
|
cerebral cortex cell migration
|
GO:0021795 |
44 |
0.042
|
|
|
|
regulation of cartilage development
|
GO:0061035 |
44 |
0.042
|
|
|
|
regulation of saliva secretion
|
GO:0046877 |
2 |
0.042
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.042
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.042
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.042
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.042
|
|
|
|
positive regulation of neutrophil migration
|
GO:1902624 |
12 |
0.042
|
|
|
|
muscle cell proliferation
|
GO:0033002 |
52 |
0.042
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.042
|
|
|
|
operant conditioning
|
GO:0035106 |
2 |
0.041
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.041
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.041
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.041
|
|
|
|
positive regulation of interleukin 8 production
|
GO:0032757 |
2 |
0.041
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.041
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.041
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.041
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.041
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.040
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.040
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.040
|
|
|
|
ovulation cycle
|
GO:0042698 |
59 |
0.040
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.040
|
|
|
|
regulation of acute inflammatory response
|
GO:0002673 |
27 |
0.040
|
|
|
|
determination of left right symmetry
|
GO:0007368 |
80 |
0.040
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.039
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.039
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.039
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.039
|
|
|
|
regulation of muscle contraction
|
GO:0006937 |
49 |
0.039
|
|
|
|
adenylate cyclase inhibiting g protein coupled receptor signaling pathway
|
GO:0007193 |
20 |
0.039
|
|
|
|
immune response regulating cell surface receptor signaling pathway
|
GO:0002768 |
80 |
0.038
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.038
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.038
|
|
|
|
positive regulation of calcium ion transport
|
GO:0051928 |
27 |
0.038
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.038
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.038
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.038
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.038
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.037
|
|
|
|
adult locomotory behavior
|
GO:0008344 |
91 |
0.037
|
|
|
|
negative regulation of vasculature development
|
GO:1901343 |
26 |
0.037
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.037
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.037
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.037
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.037
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.037
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.037
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.037
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.037
|
|
|
|
helper t cell chemotaxis
|
GO:0035704 |
1 |
0.037
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.036
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.036
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.036
|
|
|
|
protein kinase b signaling
|
GO:0043491 |
74 |
0.036
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.036
|
|
|
|
regulation of synaptic plasticity
|
GO:0048167 |
87 |
0.035
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.035
|
|
|
|
mesoderm morphogenesis
|
GO:0048332 |
64 |
0.035
|
|
|
|
defense response to virus
|
GO:0051607 |
68 |
0.035
|
|
|
|
t helper 17 cell chemotaxis
|
GO:0035705 |
1 |
0.035
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.035
|
|
|
|
face development
|
GO:0060324 |
38 |
0.035
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.034
|
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
53 |
0.034
|
|
|
|
pancreatic pp cell fate commitment
|
GO:0003329 |
2 |
0.034
|
|
|
|
bundle of his development
|
GO:0003166 |
4 |
0.034
|
|
|
|
regulation of tumor necrosis factor superfamily cytokine production
|
GO:1903555 |
50 |
0.034
|
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.034
|
|
|
|
eosinophil mediated immunity
|
GO:0002447 |
1 |
0.034
|
|
|
|
positive regulation of granulocyte chemotaxis
|
GO:0071624 |
12 |
0.034
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.034
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.034
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.034
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.034
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.033
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.033
|
|
|
|
regulation of tumor necrosis factor production
|
GO:0032680 |
49 |
0.033
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.033
|
|
|
|
optic nerve development
|
GO:0021554 |
8 |
0.033
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.033
|
|
|
|
somatostatin receptor signaling pathway
|
GO:0038169 |
2 |
0.033
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.032
|
|
|
|
positive regulation of leukocyte mediated immunity
|
GO:0002705 |
70 |
0.032
|
|
|
|
positive regulation of adenylate cyclase activity involved in g protein coupled receptor signaling pathway
|
GO:0010579 |
3 |
0.032
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.032
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.032
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.032
|
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.032
|
|
|
|
eosinophil migration
|
GO:0072677 |
3 |
0.032
|
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
64 |
0.032
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.032
|
|
|
|
cytokine secretion
|
GO:0050663 |
72 |
0.032
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.032
|
|
|
|
fibroblast growth factor production
|
GO:0090269 |
4 |
0.032
|
|
|
|
negative regulation of immune effector process
|
GO:0002698 |
55 |
0.032
|
|
|
|
cellular response to monosaccharide stimulus
|
GO:0071326 |
47 |
0.032
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.032
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.032
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.032
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.032
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.031
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.031
|
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.031
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.031
|
|
|
|
hypersensitivity
|
GO:0002524 |
10 |
0.031
|
|
|
|
regulation of t cell extravasation
|
GO:2000407 |
3 |
0.031
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.031
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.031
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.031
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.031
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.031
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.031
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.031
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.031
|
|
|
|
associative learning
|
GO:0008306 |
61 |
0.031
|
|
|
|
acetylcholine secretion neurotransmission
|
GO:0014055 |
2 |
0.031
|
|
|
|
activation of mapk activity
|
GO:0000187 |
59 |
0.031
|
|
|
|
endoderm development
|
GO:0007492 |
45 |
0.031
|
|
|
|
regulation of resting membrane potential
|
GO:0060075 |
3 |
0.031
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
78 |
0.031
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.030
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.030
|
|
|
|
regulation of carbohydrate metabolic process
|
GO:0006109 |
75 |
0.030
|
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
50 |
0.030
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.030
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.030
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.030
|
|
|
|
monoamine transport
|
GO:0015844 |
33 |
0.030
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.030
|
|
|
|
regulation of leukocyte apoptotic process
|
GO:2000106 |
56 |
0.030
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.030
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.030
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.030
|
|
|
|
interleukin 12 secretion
|
GO:0072610 |
3 |
0.030
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.029
|
|
|
|
pancreas development
|
GO:0031016 |
57 |
0.029
|
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
77 |
0.029
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.029
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.029
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.029
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.029
|
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.029
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.029
|
|
|
|
digestion
|
GO:0007586 |
40 |
0.029
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.029
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.029
|
|
|
|
negative regulation of secretion
|
GO:0051048 |
61 |
0.029
|
|
|
|
somatostatin signaling pathway
|
GO:0038170 |
2 |
0.029
|
|
|
|
conditioned taste aversion
|
GO:0001661 |
4 |
0.028
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.028
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.028
|
|
|
|
regulation of extent of cell growth
|
GO:0061387 |
52 |
0.028
|
|
|
|
regulation of production of molecular mediator of immune response
|
GO:0002700 |
65 |
0.028
|
|
|
|
positive regulation of camp mediated signaling
|
GO:0043950 |
3 |
0.028
|
|
|
|
regulation of acetylcholine secretion neurotransmission
|
GO:0014056 |
2 |
0.028
|
|
|
|
cardiac muscle cell development
|
GO:0055013 |
39 |
0.028
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.028
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.028
|
|
|
|
regulation of morphogenesis of a branching structure
|
GO:0060688 |
53 |
0.028
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.028
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.028
|
|
|
|
eosinophil degranulation
|
GO:0043308 |
1 |
0.028
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.028
|
|
|
|
cd8 positive alpha beta t cell extravasation
|
GO:0035697 |
3 |
0.028
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.028
|
|
|
|
immune complex clearance
|
GO:0002434 |
2 |
0.028
|
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.028
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.028
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.027
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.027
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.027
|
|
|
|
positive regulation of lymphocyte proliferation
|
GO:0050671 |
70 |
0.027
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.027
|
|
|
|
notch signaling pathway
|
GO:0007219 |
71 |
0.027
|
|
|
|
tumor necrosis factor biosynthetic process
|
GO:0042533 |
10 |
0.027
|
|
|
|
regulation of tumor necrosis factor biosynthetic process
|
GO:0042534 |
10 |
0.027
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.027
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.027
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.027
|
|
|
|
fibroblast growth factor receptor signaling pathway
|
GO:0008543 |
46 |
0.026
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.026
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.026
|
|
|
|
interleukin 1 secretion
|
GO:0050701 |
16 |
0.026
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.026
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.026
|
|
|
|
regulation of immune complex clearance by monocytes and macrophages
|
GO:0090264 |
2 |
0.026
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.026
|
|
|
|
positive regulation of leukocyte proliferation
|
GO:0070665 |
73 |
0.026
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.026
|
|
|
|
regulation of ion transmembrane transporter activity
|
GO:0032412 |
54 |
0.026
|
|
|
|
negative regulation of leukocyte proliferation
|
GO:0070664 |
46 |
0.026
|
|
|
|
negative regulation of leukocyte mediated immunity
|
GO:0002704 |
29 |
0.026
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.025
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.025
|
|
|
|
positive regulation of b cell activation
|
GO:0050871 |
49 |
0.025
|
|
|
|
regulation of g protein coupled receptor protein signaling pathway
|
GO:0008277 |
37 |
0.025
|
|
|
|
heart growth
|
GO:0060419 |
45 |
0.025
|
|
|
|
exocrine system development
|
GO:0035272 |
45 |
0.025
|
|
|
|
monocarboxylic acid biosynthetic process
|
GO:0072330 |
61 |
0.025
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.025
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.025
|
|
|
|
positive regulation of ion transmembrane transporter activity
|
GO:0032414 |
15 |
0.025
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.025
|
|
|
|
regulation of neutrophil migration
|
GO:1902622 |
14 |
0.025
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.025
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.025
|
|
|
|
macrophage chemotaxis
|
GO:0048246 |
14 |
0.025
|
|
|
|
positive regulation of glycoprotein metabolic process
|
GO:1903020 |
6 |
0.025
|
|
|
|
hemostasis
|
GO:0007599 |
78 |
0.025
|
|
|
|
positive regulation of cytosolic calcium ion concentration involved in phospholipase c activating g protein coupled signaling pathway
|
GO:0051482 |
4 |
0.024
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.024
|
|
|
|
calcium ion transport into cytosol
|
GO:0060402 |
48 |
0.024
|
|
|
|
myeloid leukocyte activation
|
GO:0002274 |
83 |
0.024
|
|